GERN
USDGeron Corporation Common Stock
$1.150-0.050 (-4.167%)
Precio en Tiempo Real
Healthcare
Biotecnología
Estados Unidos
Gráfico de Precios
Loading Chart...
Métricas Clave
Métricas de Mercado
Apertura
$1.200
Máximo
$1.220
Mínimo
$1.140
Volumen
8.19M
Fundamentos de la Empresa
Capitalización de Mercado
733.7M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
7.83M
Bolsa
NMS
Moneda
USD
Rango de 52 Semanas
Mínimo $1.09Actual $1.150Máximo $4.5
Noticias Relacionadas
BusinessWire
Geron Corporation to Present at Upcoming Investor Conferences
Geron Corporation (NASDAQ:GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that Harout Semerjian, Chief Executive Officer, is scheduled
Ver más
BusinessWire
Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies
New analysis from the Phase 3 IMerge clinical trial, accepted as an oral presentation, explores relationship between treatment-emergent cytopenias and clinical response in LR-MDS Additional poster presentations
Ver más
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.